These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 35428435)

  • 41. Validity of the decreased sexual desire screener for diagnosing hypoactive sexual desire disorder.
    Clayton AH; Goldfischer E; Goldstein I; DeRogatis L; Nappi R; Lewis-D'Agostino DJ; Kimura T; Hebert A; Pyke R
    J Sex Marital Ther; 2013; 39(2):132-43. PubMed ID: 23252638
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessing the Burden of Illness Associated with Acquired Generalized Hypoactive Sexual Desire Disorder.
    Simon JA; Athavale A; Ravindranath R; Hadker N; Sadiq A; Lim-Watson M; Williams L; Krop J
    J Womens Health (Larchmt); 2022 May; 31(5):715-725. PubMed ID: 35475708
    [No Abstract]   [Full Text] [Related]  

  • 43. Flibanserin and its discontents.
    Aftab A; Chen C; McBride J
    Arch Womens Ment Health; 2017 Apr; 20(2):243-247. PubMed ID: 27858170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypoactive sexual desire disorder in premenopausal women: case studies.
    Miner M; Sadovsky R; Buster JE
    Postgrad Med; 2012 Jan; 124(1):94-103. PubMed ID: 22314119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low sexual desire--is it all in her head? Pathophysiology, diagnosis, and treatment of hypoactive sexual desire disorder.
    Simon JA
    Postgrad Med; 2010 Nov; 122(6):128-36. PubMed ID: 21084789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expert opinion on existing and developing drugs to treat female sexual dysfunction.
    Miller MK; Smith JR; Norman JJ; Clayton AH
    Expert Opin Emerg Drugs; 2018 Sep; 23(3):223-230. PubMed ID: 30251897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of testosterone in the treatment of hypoactive sexual desire disorder.
    Schwenkhagen A; Studd J
    Maturitas; 2009 Jun; 63(2):152-9. PubMed ID: 19359109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of flibanserin in managing hypoactive sexual desire disorder in women: A systematic review and meta-analysis.
    Kamrul-Hasan ABM; Hannan MA; Alam MS; Aalpona FTZ; Nagendra L; Selim S; Dutta D
    Medicine (Baltimore); 2024 Jun; 103(25):e38592. PubMed ID: 38905407
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Weight Loss in Women Taking Flibanserin for Hypoactive Sexual Desire Disorder (HSDD): Insights Into Potential Mechanisms.
    Simon JA; Kingsberg SA; Goldstein I; Kim NN; Hakim B; Millheiser L
    Sex Med Rev; 2019 Oct; 7(4):575-586. PubMed ID: 31196764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of Tribulus Terrestris for the treatment of premenopausal women with hypoactive sexual desire disorder: a randomized double-blinded, placebo-controlled trial.
    Vale FBC; Zanolla Dias de Souza K; Rezende CR; Geber S
    Gynecol Endocrinol; 2018 May; 34(5):442-445. PubMed ID: 29172782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial.
    Clayton AH; Althof SE; Kingsberg S; DeRogatis LR; Kroll R; Goldstein I; Kaminetsky J; Spana C; Lucas J; Jordan R; Portman DJ
    Womens Health (Lond); 2016 Jun; 12(3):325-37. PubMed ID: 27181790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Testosterone therapy in women: a review.
    Bolour S; Braunstein G
    Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review.
    Goldstein I; Kim NN; Clayton AH; DeRogatis LR; Giraldi A; Parish SJ; Pfaus J; Simon JA; Kingsberg SA; Meston C; Stahl SM; Wallen K; Worsley R
    Mayo Clin Proc; 2017 Jan; 92(1):114-128. PubMed ID: 27916394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. First Pharmacological Therapy for Hypoactive Sexual Desire Disorder in Premenopausal Women: Flibanserin.
    Robinson K; Cutler JB; Carris NW
    Ann Pharmacother; 2016 Feb; 50(2):125-32. PubMed ID: 26692273
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and Predictors of Low Sexual Desire, Sexually Related Personal Distress, and Hypoactive Sexual Desire Dysfunction in a Community-Based Sample of Midlife Women.
    Worsley R; Bell RJ; Gartoulla P; Davis SR
    J Sex Med; 2017 May; 14(5):675-686. PubMed ID: 28499520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Understanding the Role of Serotonin in Female Hypoactive Sexual Desire Disorder and Treatment Options.
    Croft HA
    J Sex Med; 2017 Dec; 14(12):1575-1584. PubMed ID: 29198512
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Sexual Interest and Desire Inventory-Female (SIDI-F): item response analyses of data from women diagnosed with hypoactive sexual desire disorder.
    Sills T; Wunderlich G; Pyke R; Segraves RT; Leiblum S; Clayton A; Cotton D; Evans K
    J Sex Med; 2005 Nov; 2(6):801-18. PubMed ID: 16422805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Why are there no FDA-approved treatments for female sexual dysfunction?
    Nappi RE
    Expert Opin Pharmacother; 2015; 16(12):1735-8. PubMed ID: 26165387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction.
    Kingsberg SA; Althof SE
    J Sex Med; 2011 Dec; 8(12):3262-70. PubMed ID: 21883949
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypoactive sexual desire in women.
    Kingsberg SA; Rezaee RL
    Menopause; 2013 Dec; 20(12):1284-300. PubMed ID: 24219879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.